Discounted Cash Flow Rating
Neutral
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Strong Sell
Price to Earnings Rating
Strong Sell
Analyst Rating
Sell
Wall Street Data Solutions Rating
Neutral
B
Alaunos Therapeutics, Inc. Common Stock (TCRT)
Pharmaceutical Preparations
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens (neoAg) arising from genomic mutations.
8030 EL RIO STREET
HOUSTON, TX
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
08/24/2005
Market Cap
3,807,612
Shares Outstanding
240,630,000
Weighted SO
240,627,055
Total Employees
N/A
Upcoming Earnings
N/A
Beta
-0.4930
Last Div
0.0000
Range
2.29-33.0
Chg
0.0179
Avg Vol
12236
Mkt Cap
3807612
Exch
NASDAQ
Country
US
Phone
346 355 4099
DCF Diff
1.9776
DCF
0.3724
Div Yield
0.0000
P/S
634.6020
EV Multiple
-0.1085
P/FV
1.0097
Div Yield %
0.0000
P/E
-0.1990
PEG
-4.6527
Payout
0.0000
Current Ratio
5.1577
Quick Ratio
5.1577
Cash Ratio
2.7155
DSO
243.3333
DIO
0.0000
Op Cycle
243.3333
DPO
101.8540
CCC
141.4794
Gross Margin
-217.0000
Op Margin
-2488.6667
Pretax Margin
-3188.3333
Net Margin
-3188.3333
Eff Tax Rate
0.0361
ROA
-4.0894
ROE
-2.6593
ROCE
-3.9597
NI/EBT
1.0000
EBT/EBIT
1.2811
EBIT/Rev
-2488.6667
Debt Ratio
0.0000
D/E
0.0000
LT Debt/Cap
0.0000
Total Debt/Cap
0.0000
Int Coverage
3.8865
CF/Debt
0.0000
Equity Multi
1.2405
Rec Turnover
1.5000
Pay Turnover
3.5836
Inv Turnover
0.0000
FA Turnover
0.0000
Asset Turnover
0.0013
OCF/Share
-10.8396
FCF/Share
-10.8403
Cash/Share
1.5382
OCF/Sales
-2892.8333
FCF/OCF
1.0001
CF Coverage
0.0000
ST Coverage
0.0000
CapEx Coverage
-17357.0000
Div&CapEx Cov
-17357.0000
P/BV
1.0097
P/B
1.0097
P/S
634.6020
P/E
-0.1990
P/FCF
-0.2194
P/OCF
-0.2194
P/CF
-0.2194
PEG
-4.6527
P/S
634.6020
EV Multiple
-0.1085
P/FV
1.0097
DPS
0.0000
Latest Headlines (EST)
Revenue Product Segmentation
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | X | X | X | X | ▲ XXXXX | ▼ 1.00K | 1.00K |
Cost Of Revenue | X | X | X | X | ▲ XXXXXX | ▼ 241.00K | ▼ 2.00K |
Gross Profit | X | X | X | X | ▼ -XXXXXX | ▲ -240.00K | ▲ -1.00K |
Gross Profit Ratio | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | ▼ -XX.XXXXXXXXXX | ▼ -100.00 | ▲ -1.00 |
Research And Development Expenses | XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▼ 933.00K | ▼ 126.00K |
General And Administrative Expenses | XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXX | ▼ 2.43M | ▼ 1.62M |
Selling And Marketing Expenses | X | X | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXX | ▲ -241.00K | ▲ -2.00K |
Selling General And Administrative Expenses | XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▼ 2.19M | ▼ 1.62M |
Other Expenses | XXXXXX | ▲ XXXXXX | ▼ XXXX | ▼ -XXXXXX | ▲ XXXXXX | ▼ 106.00K | ▼ 60.00K |
Operating Expenses | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXX | ▼ 3.12M | ▼ 1.74M |
Cost And Expenses | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXX | ▼ 3.36M | ▼ 1.74M |
Interest Income | X | X | X | X | X | 0.00 | 0.00 |
Interest Expense | -XXXXXX | ▼ -XXXXXX | ▲ -XXXX | ▲ XXXXXX | ▲ XXXXXX | ▼ -3.84M | ▲ 0.00 |
Depreciation And Amortization | XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▼ XXXXXX | ▼ 241.00K | ▼ 2.00K |
Ebitda | -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXX | ▲ -XXXXXXX | ▲ -3.12M | ▲ -1.74M |
Ebitda Ratio | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | ▼ -XX.XXXXXXXXXX | -100.00 | -100.00 |
Operating Income | -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▲ -XXXXXXX | ▲ -3.36M | ▲ -1.74M |
Operating Income Ratio | X.XXXXXXXXX | X.XXXXXXXXX | X.XXXXXXXXX | X.XXXXXXXXX | ▼ -XXX.XXXXXXXXX | ▼ -1,000.00 | -1,000.00 |
Total Other Income Expenses Net | XXXXXX | ▲ XXXXXX | ▼ XXXX | ▼ -XXXXXXX | ▲ -XXXXXX | ▼ -4.48M | ▲ 60.00K |
Income Before Tax | -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▲ -XXXXXXX | ▲ -7.84M | ▲ -1.68M |
Income Before Tax Ratio | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | ▼ -XX.XXXXXXXXXX | -100.00 | -100.00 |
Income Tax Expense | -XXXXXX | ▲ -XXXXXX | ▲ -XXXX | ▲ XXXXXX | ▼ XXXXXX | ▼ -837.00K | ▲ 0.00 |
Net Income | -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▲ -XXXXXXX | ▲ -7.84M | ▲ -1.68M |
Net Income Ratio | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | ▼ -XX.XXXXXXXXXX | -100.00 | -100.00 |
Eps | -X.XX | ▼ -X.XX | ▼ -X.XX | ▲ -X.XX | ▼ -X.XX | ▲ -0.49 | ▲ -0.11 |
Eps Diluted | -X.XX | ▼ -X.XX | ▼ -X.XX | ▲ -X.XX | ▼ -X.XX | ▲ -0.49 | ▲ -0.11 |
Weighted Average Shs Out | XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXX | ▲ 16.01M | ▲ 16.01M |
Weighted Average Shs Out Dil | XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXX | ▲ 16.01M | ▲ 16.01M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▼ 6.06M | ▼ 4.14M |
Short Term Investments | X | X | X | X | X | 0.00 | 0.00 |
Cash And Short Term Investments | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▼ 6.06M | ▼ 4.14M |
Net Receivables | XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▼ XXXX | ▼ 1.00K | 1.00K |
Inventory | X | X | X | X | ▲ XXXXXXXX | ▼ 0.00 | ▲ 1.00 |
Other Current Assets | XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXX | ▼ XXXXXX | ▲ 2.20M | ▼ 1.89M |
Total Current Assets | XXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▼ 8.26M | ▼ 6.04M |
Property Plant Equipment Net | XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▼ 2.00K | ▼ 0.00 |
Goodwill | X | X | X | X | X | 0.00 | 0.00 |
Intangible Assets | X | X | X | X | X | 0.00 | 0.00 |
Goodwill And Intangible Assets | X | X | X | X | X | 0.00 | 0.00 |
Long Term Investments | X | X | X | X | X | 0.00 | 0.00 |
Tax Assets | X | X | X | X | X | 0.00 | 0.00 |
Other Non Current Assets | XXXXXXX | ▼ XXXXXX | ▲ XXXXXX | ▼ XXXXXX | ▼ XXXXXX | ▼ 0.00 | 0.00 |
Total Non Current Assets | XXXXXXXX | ▼ XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▼ 2.00K | ▼ 0.00 |
Other Assets | X | X | X | X | X | ▲ 1.00 | ▼ 0.00 |
Total Assets | XXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▼ 8.26M | ▼ 6.04M |
Account Payables | XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▼ 616.00K | ▼ 597.00K |
Short Term Debt | XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ XXXXXXX | ▲ XXXXXXXX | ▼ 0.00 | 0.00 |
Tax Payables | XXXXXX | ▼ XXXXXX | ▼ XXXXX | ▼ X | X | 0.00 | 0.00 |
Deferred Revenue | -XXXXXX | ▲ X | X | X | X | 0.00 | 0.00 |
Other Current Liabilities | XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▼ 1.34M | ▼ 643.00K |
Total Current Liabilities | XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▼ 1.96M | ▼ 1.24M |
Long Term Debt | X | ▲ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXX | ▼ 0.00 | 0.00 |
Deferred Revenue Non Current | X | X | X | X | X | 0.00 | 0.00 |
Deferred Tax Liabilities Non Current | X | X | X | X | X | 0.00 | 0.00 |
Other Non Current Liabilities | XXXX | ▼ X | X | ▼ -XXXX | ▲ XXXXX | ▼ 0.00 | 0.00 |
Total Non Current Liabilities | XXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXX | ▼ 0.00 | 0.00 |
Other Liabilities | X | ▲ XXXXXXXX | ▼ X | X | X | 0.00 | 0.00 |
Capital Lease Obligations | X | ▲ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▼ 0.00 | 0.00 |
Total Liabilities | XXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▼ 1.96M | ▼ 1.24M |
Preferred Stock | X | X | X | X | X | 0.00 | 0.00 |
Common Stock | XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▼ 16.00K | 16.00K |
Retained Earnings | -XXXXXXXXX | ▼ -XXXXXXXXX | ▼ -XXXXXXXXX | ▼ -XXXXXXXXX | ▼ -XXXXXXXXX | ▼ -915.77M | ▼ -917.45M |
Accumulated Other Comprehensive Income Loss | X | X | X | X | X | 0.00 | 0.00 |
Other Total Stockholders Equity | XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ 922.06M | ▲ 922.23M |
Total Stockholders Equity | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▼ 6.31M | ▼ 4.80M |
Total Equity | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▼ 6.31M | ▼ 4.80M |
Total Liabilities And Stockholders Equity | XXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▼ 8.26M | ▼ 6.04M |
Minority Interest | X | X | X | X | X | 0.00 | 0.00 |
Total Liabilities And Total Equity | XXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▼ 8.26M | ▼ 6.04M |
Total Investments | X | X | X | X | X | 0.00 | 0.00 |
Total Debt | X | ▲ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▼ 0.00 | 0.00 |
Net Debt | -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXXX | ▲ -XXXXXXXX | ▲ -XXXXXXXX | ▲ -6.06M | ▲ -4.14M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▲ -XXXXXXX | ▲ -7.84M | ▲ -1.68M |
Depreciation And Amortization | XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▼ XXXXXX | ▼ 241.00K | ▼ 2.00K |
Deferred Income Tax | X | ▲ XXXXXXXX | ▼ -XXXXXXXX | ▲ XXXXXX | ▼ X | ▼ -1.41M | ▲ 0.00 |
Stock Based Compensation | XXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▼ XXXXXX | ▼ XXXXXX | ▼ 250.00K | ▼ 172.00K |
Change In Working Capital | -XXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▼ -XXXXXXX | ▲ -XXXX | ▼ -2.72M | ▲ -409.00K |
Accounts Receivables | XXXX | ▼ -XXXXXXX | ▲ -XXXXXXX | ▲ XXXXXXX | ▼ -XXXX | ▲ -1.00K | ▲ 0.00 |
Inventory | XXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▼ X | X | 0.00 | 0.00 |
Accounts Payables | -XXXXXX | ▲ -XXXXX | ▼ -XXXXXXX | ▲ -XXXXXX | ▼ -XXXXXX | ▼ -681.00K | ▲ -19.00K |
Other Working Capital | -XXXXX | ▼ -XXXXX | ▼ -XXXXXXX | ▼ -XXXXXXX | ▲ XXXXXX | ▼ -2.04M | ▲ -390.00K |
Other Non Cash Items | -XXXXXX | ▼ -XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXX | ▲ XXXXXX | ▲ 4.10M | ▼ 195.00K |
Net Cash Provided By Operating Activities | -XXXXXXXX | ▲ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▲ -XXXXXXX | ▼ -7.39M | ▲ -1.92M |
Investments In Property Plant And Equipment | XXXXX | ▼ -XXXXXX | ▼ -XXXXXXX | ▲ -XXXXXX | ▲ -XXXXXX | ▲ 0.00 | 0.00 |
Acquisitions Net | X | X | X | X | ▲ XXXXX | ▲ 1.50M | ▼ 0.00 |
Purchases Of Investments | X | X | X | X | X | 0.00 | 0.00 |
Sales Maturities Of Investments | X | X | X | X | X | 0.00 | 0.00 |
Other Investing Activities | X | X | X | X | X | ▲ 1.54M | ▼ 0.00 |
Net Cash Used For Investing Activities | XXXXX | ▼ -XXXXXX | ▼ -XXXXXXX | ▲ -XXXXXX | ▲ -XXXXX | ▲ 1.50M | ▼ 0.00 |
Debt Repayment | -XXXXXXXX | ▲ -XXXXXXXX | ▲ X | ▼ -XXXXXX | ▼ -XXXXXXX | ▲ -125.00K | ▲ 0.00 |
Common Stock Issued | XXXXXXXX | ▼ XXXXXXX | ▼ XXXX | ▲ XXXXXXX | ▲ XXXXXXXX | ▼ 0.00 | 0.00 |
Common Stock Repurchased | -XXXXXX | ▲ -XXXXXX | ▼ -XXXXXX | ▲ X | ▼ -XXXXX | ▲ 0.00 | 0.00 |
Dividends Paid | -XXXXXXXX | ▲ -XXXXXXXX | ▲ X | X | X | 0.00 | 0.00 |
Other Financing Activities | XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXX | ▼ -XXXXXX | ▲ XXXXX | ▼ -18.11M | ▲ 0.00 |
Net Cash Used Provided By Financing Activities | XXXXXXXX | ▼ XXXXXXX | ▼ XXXXXX | ▼ -XXXXXX | ▲ XXXXXXX | ▼ 0.00 | 0.00 |
Effect Of Forex Changes On Cash | -XXXX | ▲ X | X | X | X | 0.00 | 0.00 |
Net Change In Cash | XXXXXXXX | ▼ -XXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▲ XXXXXXX | ▼ -5.88M | ▲ -1.92M |
Cash At End Of Period | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▼ 6.06M | ▼ 4.14M |
Cash At Beginning Of Period | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▼ 11.94M | ▼ 6.06M |
Operating Cash Flow | -XXXXXXXX | ▲ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▲ -XXXXXXX | ▼ -7.39M | ▲ -1.92M |
Capital Expenditure | XXXXX | ▼ -XXXXXX | ▼ -XXXXXXX | ▲ -XXXXXX | ▲ -XXXXXX | ▲ 0.00 | 0.00 |
Free Cash Flow | -XXXXXXXX | ▲ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▲ -XXXXXXX | ▼ -7.39M | ▲ -1.92M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Upgrade To Get Access
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Dicta eveniet ex illo maxime minima numquam quibusdam reprehenderit temporibus vel, voluptatum? Delectus eos eveniet id iusto necessitatibus, neque porro unde voluptatibus. Aut blanditiis commodi, iste iure laborum pariatur temporibus. Atque distinctio dolore, doloremque eaque eius harum inventore laudantium quibusdam recusandae voluptatibus.